Health Library

Cirrhosis

Liver cirrhosis; Chronic liver disease; End-stage liver disease; Liver failure - cirrhosis; Ascites - cirrhosis

Cirrhosis is scarring of the liver that results in poor liver function. It is the last stage of chronic liver disease.

Images

I Would Like to Learn About:

Causes

Cirrhosis is most often the end result of chronic liver damage caused by long-term (chronic) liver disease. Common causes of chronic liver disease in the United States are:

• Hepatitis B or hepatitis C infection.
• Alcohol overuse.
• Buildup of fat in the liver that is NOT caused by drinking too much alcohol (called metabolic dysfunction associated steatotic liver disease [MASLD] or metabolic dysfunction associated steatohepatitis [MASH]). It is closely related to being overweight, having high blood pressure, diabetes or pre-diabetes, and high cholesterol.

Less common causes of cirrhosis include:

• Autoimmune hepatitis (AH): when immune cells mistake the liver's normal cells for harmful invaders and attack them
• Bile duct disorders
• Some medicines
• Liver diseases passed down in families

Symptoms

There may be no symptoms, or symptoms may come on slowly, depending on how well the liver is working. Often, it is discovered by chance when an abdominal ultrasound exam is done or blood is drawn for another reason.

Early symptoms include:

• Fatigue and loss of energy
• Poor appetite and weight loss
• Nausea or belly pain
• Small, red spider-like blood vessels on the skin

As liver function worsens, symptoms may include:

• Fluid buildup in the legs (edema) or in the abdomen (ascites)
• Yellow color in the skin, mucous membranes, or eyes (jaundice)
• Redness on the palms of the hands
• In men, impotence, shrinking of the testicles, and breast swelling
• Easy bruising and abnormal bleeding, most often from swollen veins in the digestive tract
• Confusion or problems thinking
• Pale or clay-colored stools
• Bleeding from upper or lower gastrointestinal tract

Exams and Tests

Your health care provider will do a physical exam to look for:

• An enlarged liver or spleen
• Excess breast tissue (in men)
• Swollen abdomen, as a result of too much fluid
• Swollen legs
• Reddened palms
• Red spider-like blood vessels on the skin
• Small testicles (in men)
• Widened veins in the abdomen wall
• Yellow eyes or skin (jaundice)

You may have the following tests to determine the cause of your cirrhosis:

• Hepatitis virus testing
• Antibody testing for autoimmune hepatitis
• Serum iron saturation and ferritin levels
• Serum ceruloplasmin level
• Genetic testing for liver diseases

You may have the following tests to measure liver function:

• Complete blood count
• Prothrombin time
• Liver function tests
• Blood albumin level

Other tests to check for liver damage include:

• CT of the abdomen
• MRI of the abdomen
• Endoscopy to check for abnormal veins in the esophagus or stomach
• Ultrasound of the abdomen
• FibroScan (a special ultrasound that measures stiffness and fat content in the liver)

You might need a liver biopsy to confirm the diagnosis.

Treatment

LIFESTYLE CHANGES

Some things you can do to help take care of your liver disease are:

• Drink no alcohol.
• Eat a healthy diet that is low in salt, fat, and simple carbohydrates.
• Get vaccinated for diseases such as influenza, COVID-19, hepatitis A and B, and pneumococcal disease.
• Talk to your provider about all medicines you take, including herbs and supplements and over-the-counter medicines.
• Exercise.
• Control your underlying metabolic problems, such as high blood pressure, diabetes, and high cholesterol.

MEDICINES FROM YOUR PROVIDER

• Water pills (diuretics) to get rid of fluid build-up.
• Vitamin K or blood products to prevent excess bleeding.
• Medicines for mental confusion.
• Antibiotics for infections.
• Medicines to cure Hepatitis C.
• Medicines to cure Hepatitis B.
• New medicines are being created to treat MASH. Resmetirom (Rezdiffra) was recently approved by the FDA. Your provider can discuss whether you should be treated with this medicine.

OTHER TREATMENTS

• Endoscopic treatments for enlarged veins in the esophagus (varices)
• Removal of fluid from the abdomen (paracentesis)
• Placement of a transjugular intrahepatic portosystemic shunt (TIPS) to improve blood flow in the liver

When cirrhosis progresses to end-stage liver disease, a liver transplant may be needed.

Support Groups

You can often ease the stress of illness by joining a liver disease support group whose members share common experiences and problems.

Outlook (Prognosis)

Cirrhosis is caused by scarring of the liver. In most cases, the liver cannot heal or return to normal function once the damage is severe. Cirrhosis can lead to serious complications.

Possible Complications

Complications may include:

• Bleeding disorders
• Buildup of fluid in the abdomen (ascites) and infection of the fluid (spontaneous bacterial peritonitis)
• Enlarged veins in the esophagus, stomach, or intestines that bleed easily (varices)
• Increased pressure in the blood vessels of the liver (portal hypertension)
• Kidney failure (hepatorenal syndrome)
• Liver cancer (hepatocellular carcinoma)
• Mental confusion, change in the level of consciousness, or coma (hepatic encephalopathy)

When to Contact a Medical Professional

Contact your provider if you develop symptoms of cirrhosis.

Get emergency medical help right away if you have:

• Abdominal or chest pain
• Abdominal swelling or ascites that is new or suddenly becomes worse
• A fever (temperature greater than 101°F or 38.3°C)
• Diarrhea
• Confusion or a change in alertness, or it gets worse
• Rectal bleeding, vomiting blood, or blood in the urine
• Shortness of breath
• Vomiting more than once a day
• Yellowing skin or eyes (jaundice) that is new or gets worse quickly

Prevention

DO NOT drink alcohol. Talk to your provider if you are worried about your drinking. Take steps to prevent getting hepatitis B or C or passing it to other people.

Related Information

References

Garcia-Tsao G. Cirrhosis and its sequelae. In: Goldman L, Cooney KA, eds. Goldman-Cecil Medicine. 27th ed. Philadelphia, PA: Elsevier; 2024:chap 139.

Kamath PS, Shah VH. Overview of cirrhosis. In: Chung RT, Rubin DT, Wilcox CM, eds. Sleisenger and Fordtran's Gastrointestinal and Liver Disease. 12th ed. Philadelphia, PA: Elsevier; 2026:chap 76.

Rinella ME, Lazarus JV, Ratziu V, et al. A multisociety Delphi consensus statement on new fatty liver disease nomenclature. J Hepatol. 2023;79(6):1542-1556. PMID: 37354790 pubmed.ncbi.nlm.nih.gov/37364790/.

Tiwari A, Sharma A, Kumar H, et al. Resmetirom for MASH: A comprehensive review of a novel therapeutic frontier. Biomedicines. 2025;13(9):2079. PMID: 41007643 pubmed.ncbi.nlm.nih.gov/41007643/.

Review Date: 1/13/2026  

Reviewed By: Todd Eisner, MD, Private practice specializing in Gastroenterology in Boca Raton and Delray Beach, Florida at Gastroenterology Consultants of Boca Raton. Affiliate Assistant Professor, Florida Atlantic University School of Medicine. Review provided by VeriMed Healthcare Network. Also reviewed by David C. Dugdale, MD, Medical Director, Brenda Conaway, Editorial Director, and the A.D.A.M. Editorial team.

A.D.A.M., Inc. is accredited by URAC, for Health Content Provider (www.urac.org). URAC's accreditation program is an independent audit to verify that A.D.A.M. follows rigorous standards of quality and accountability. A.D.A.M. is among the first to achieve this important distinction for online health information and services. Learn more about A.D.A.M.'s editorial policy, editorial process and privacy policy. A.D.A.M. is also a founding member of Hi-Ethics. This site complies with the HONcode standard for trustworthy health information: verify here.

The information provided herein should not be used during any medical emergency or for the diagnosis or treatment of any medical condition. A licensed medical professional should be consulted for diagnosis and treatment of any and all medical conditions. Links to other sites are provided for information only -- they do not constitute endorsements of those other sites. No warranty of any kind, either expressed or implied, is made as to the accuracy, reliability, timeliness, or correctness of any translations made by a third-party service of the information provided herein into any other language.

© 1997- 2026 A.D.A.M., a business unit of Ebix, Inc. Any duplication or distribution of the information contained herein is strictly prohibited.

All content on this site including text, images, graphics, audio, video, data, metadata, and compilations is protected by copyright and other intellectual property laws. You may view the content for personal, noncommercial use. Any other use requires prior written consent from Ebix. You may not copy, reproduce, distribute, transmit, display, publish, reverse-engineer, adapt, modify, store beyond ordinary browser caching, index, mine, scrape, or create derivative works from this content. You may not use automated tools to access or extract content, including to create embeddings, vectors, datasets, or indexes for retrieval systems. Use of any content for training, fine-tuning, calibrating, testing, evaluating, or improving AI systems of any kind is prohibited without express written consent. This includes large language models, machine learning models, neural networks, generative systems, retrieval-augmented systems, and any software that ingests content to produce outputs. Any unauthorized use of the content including AI-related use is a violation of our rights and may result in legal action, damages, and statutory penalties to the fullest extent permitted by law. Ebix reserves the right to enforce its rights through legal, technological, and contractual measures.